The paper considers the problem of determining the number of matched sets in 1 : M matched casecontrol studies with a categorical exposure having k þ 1 categories, k ! 1. The basic interest lies in constructing a test statistic to test whether the exposure is associated with the disease. Estimates of the k odds ratios for 1 : M matched case-control studies with dichotomous exposure and for 1 : 1 matched case-control studies with exposure at several levels are presented in Breslow and Day (1980) , but results holding in full generality were not available so far. We propose a score test for testing the hypothesis of no association between disease and the polychotomous exposure. We exploit the power function of this test statistic to calculate the required number of matched sets to detect specific departures from the null hypothesis of no association. We also consider the situation when there is a natural ordering among the levels of the exposure variable. For ordinal exposure variables, we propose a test for detecting trend in disease risk with increasing levels of the exposure variable. Our methods are illustrated with two datasets, one is a real dataset on colorectal cancer in rats and the other a simulated dataset for studying disease-gene association.
Introduction
In popular epidemiologic study designs, such as case-control, case-cohort, and nested case-control design, often there is a significant amount of cost and time involved in sampling the units, especially for a rare disease. In such situations, one would like to determine the number of sampling units required to detect specific departures from the hypothesis of interest at the planning stages of the experiment (Schlesselman, 1974) . For a individually matched case-control design, a case is matched with one or more controls with respect to a set of confounding variables. The design itself is hard to implement as it becomes necessary to determine the appropriate set of controls and collect information on them. For such designs one would like to know the number of matched sets needed to attain desired level of accuracy. In the present article, we propose a method for determining the number of matched sets for 1 : M (M ! 1) matched case-control studies with a categorical exposure variable having k þ 1, k ! 1 categories.
Though stratification is often introduced in epidemiologic designs to control the effects of confounding, there is only a limited amount of literature on determining the number of matched sets for highly stratified studies with categorical exposure. Analyzing exposure data with the existing cate-gories can throw some light on the underlying nature of disease-exposure association which may be obscured if one simply dichotomizes the categorical exposure variable. For example, in genetic association studies, interest lies in the association between a disease and a candidate gene. If one assumes a bi-allelic marker locus for the candidate gene, there would be three possible genotypes (three categories of the exposure variable), and sometimes dichotomization of the genotype may hide the true nature of association specially for the complex diseases which do not obey single-gene dominant or single-gene recessive Mendallian law (Jarvik, 1998) .
Sample size determination is an important aspect in any comparative study. For individually matched case-control studies with binary exposure, standard formulas for sample size determination is available in Schlesselman (1982) . Parker and Bregman (1986) proposed sample size determination strategy for 1 : M matched case-control studies with a binary exposure variable taking into account the heterogeneity in exposure prevalence among the controls in different matched sets. Dupont (1988) considered sample size selection problems for 1 : M matched case control studies taking the association for the exposure between matched case and control patients into account. Recently Nam (1992) , Nam and Fears (1992a, b) , and Nam (1997) considered the same problem for general case-control study designs. Breslow and Day (1980) contains other methods of sample size determination for polychotomous exposure variable in unmatched and 1 : 1 matched case-control studies and for binary exposure variable in 1 : M (M > 1) matched case-control study designs. However, to the best our knowledge, there is no work on sample size determination for 1 : M matched case-control studies with a polychotomous exposure variable.
In order to determine sample size for matched case-control studies with categorical exposure variable one can use likelihood ratio (LR) test, Wald test, or score test (Rao, 1947) . Both the LR test and Wald test require calculation of maximum likelihood estimates (MLE) of the model parameters under the alternative hypothesis which in turn needs substantial computational effort for solving a system of nonlinear equations. Therefore, we focus on score test for the hypothesis of our interest, and exploiting the power function of the test we derive the required sample size, that is the number of matched sets required to detect a specified departure from the null hypothesis with certain probability. When there is a natural ordering among the levels of the exposure variable, we propose a test for detecting the presence of a trend in disease risk with increasing levels of the exposure variable and derive the power function of the proposed test. Sample sizes for trend detection are based on this power function. The attractive features of using the score test are two-fold. First, it does not require computation of the MLE's of the parameters under the alternative hypothesis, and second, it has similar first order asymptotic property as Wald and Likelihood ratio test under both the null and Pitman type alternative hypothesis (Serfling, 1980, pp. 156) . However one must recognize that inspite of the first order asymptotic equivalence, finite sample properties of these three types of test could be different, depending on the nature of the problem (Lusbader, Moolgavkar and Venzon, 1984) . Due to difficulties involved in computing the MLE the score test seems to be a preferable alternative in this situation. The score test has many other attractive and well-known theoretical features and is also most powerful for local alternatives (Cox and Hinkley, 1974, p. 113) . As one referee has pointed out, determining sample size by using the score test may serve as a good precursor even when other test statistics are used at the analysis stage.
Two datasets have been analyzed in this paper. We apply the proposed method to these datasets and then perform a small scale simulation study motivated by the examples to determine required sample sizes for various combinations of the odds ratio parameters. The first one is a real dataset on colorectal cancer of rats (Hong et al., 2001) . We explore the association between apoptosis and proliferation in stem cells in rats, the data structure is decried in detail in Section 6.1. The second one is a simulated dataset following a real genetic data on allele frequencies of 12 marker loci in Buenos Aires metropolitan population (Sala et al., 1999) . Among several marker loci, F13A is chosen as the candidate gene associated with a disease we simulated. We consider the most frequent allele at this marker locus to be the disease causing allele. Using the genotypes at this marker locus as a categorical exposure variable we generate a hypothetical matched case-control dataset and apply our method to test the hypothesis of no association between the disease and the candidate gene. The examples presented in this paper represent two different situations, one when the prevalence value of some exposure categories are very rare and when the prevalence values are moderate. In both the situations we calculate the test statistics and determine sample sizes from given prevalence values of the exposure variable. We also carry out the test for detecting trend in disease risk for both the examples. Both of these examples share a common feature that collecting data on study units is expensive (in example 1, it is through examination of colon cells, in example 2, through genotyping), and thus determining the right sample size can substantially save resources.
Most of the currently available literature on sample size determination in matched studies is for dichotomous exposure. In context of the two data examples we dichotomize the exposure variable, and then compare the sample sizes required by our method and the ad hoc method proposed by Schlesselman (1982) for a set of plausible values of the odds ratio.
The rest of the article is organized as follows. Model and notations are described in Section 2. Test procedures for a general polychotomous exposure is considered in Section 3, while Section 4 contains a special treatment of ordinal variables. In Section 5 we discuss the sample size determination problem. Section 6 contains numerical examples based on the real datasets and some simulation results. Section 7 contains concluding remarks. Details of some formulae are relegated to the Appendix.
Before we conclude this section we highlight some of the main features of this article. First, we propose a test of the hypothesis of independence of the exposure and the disease variable in a 1 : M matched case-control study with polychotomous exposure variable. For an ordinal exposure variable we propose a test for detecting a trend in disease risk with increasing levels of the exposure variable. Second, we consider the problem of sample size determination for 1 : M matched case-control studies with polychotomous exposure variable. Finally, one major advantage of the proposed method is that the test statistics are very easy to calculate simply by using the knowledge of the discordant matched sets. Using the distribution of the MLE's obtained from conditional logistic regression which is the classical method of analyzing matched case-control data, to determine the sample size will require more computation.
Model and Assumptions
Suppose we have N matched sets and each matched set consists of 1 case and M controls. Let X be a single exposure variable. Assume that the exposure variable has k þ 1 categories, denoted by 0, 1; . . . ; k. Although we use numerical indices to denote the exposure levels, these categories are in nominal scale, and 0 is assumed to be the baseline category. Let p 0h and p 1h denote the prevalence of h-th level of the exposure variable among the control and case population respectively, i.e.,
Suppose w h be the ratio of odds of disease in exposure category h to that of the category 0. So
By definition w 0 ¼ 1. We assume that the odds ratios are the same across the matched sets. The goal is to test the hypothesis H 0 :
e., the exposure variable and the disease outcome are independent. The alternative hypothesis is that at least one of w j , j ¼ 1; . . . ; k is different from 1.
Methods
As the formulation for general k is very complicated, we first derive the case for k ¼ 2. Following the same structure of argument, we derive the formula for any general k in Appendix 1. We focus our attention only to the discordant matched sets as the concordant matched sets are noninformative regarding the parameters of our interest (Breslow and Day (1980) , pp 164). For 1 : M (M ! 1) matched study with polychotomous exposure variable the concordant sets are those where case and controls are exposed to the same level of exposure variable, and the discordant sets are defined as the matched sets with at least two distinct levels of the exposure variable being present.
The probability that a matched set has m 1 subjects exposed at the level 1 and m 2 subjects exposed at the level 2 along with the restrictions m 1 ! 1, m 2 ! 1, and m 1 þ m 2 M, is given by, p m 1 ; m 2 ¼ Pr ðcase is exposed at the level 0; and m 1 and m 2 controls are exposed at the level 1 and 2 respectivelyÞ þ Pr ðcase is exposed at the level 1; and m 1 À 1 and m 2 controls are exposed at the level 1 and 2 respectivelyÞ þ Pr ðcase is exposed at the level 2; and m 1 and m 2 À 1 controls are exposed at the level 1 and 2 respectivelyÞ
be the total number of matched sets where m 1 subjects are exposed at the level 1 and m 2 are exposed at the level 2 of the exposure variable while n 
where p 1jm 1 ;m 2 ¼ Pr ðcase is exposed at the level 1 j m 1 and m 2 subjects are exposed at the levels 1 and 2 respectivelyÞ ¼ m 1 w 1 =fm 1 w 1 þ m 2 w 2 þ ðM À m 1 À m 2 þ 1Þg and similarly the other conditional probability is
be the number of matched sets where m subjects are exposed at the level i and the rest are exposed at the level j of the exposure variable. Here i and j are different and i; j ¼ 0; 1; 2; and m ¼ 1; 2; . . . ; M. So the total number of discordant matched sets is
where IðÁÞ is an indicator function. We write T ¼ Pr ða matched set has m subjects exposed at the level i; and the rest are exposed at the level jÞ ¼ Pr ð the case is exposed at the level i; m À 1 controls are exposed at the level i; and the rest are exposed at the level jÞ þ Pr ð the case is exposed at the level j; m controls are exposed at the level i; and the rest are exposed at the level jÞ
Hence conditional on T ði; jÞ m , n iði; jÞ m follows a binomial distribution with success probability
The conditional probability given in (6) turns into Eq. (5.13) of Breslow and Day (1980) if one assumes only two levels of the exposure variable. The likelihood function of the odds ratios for the matched case-control data is 
The proposed score statistic for testing H 0 is,
where
Where
and,
represent the total number of discordant matched sets where the case is exposed at the level 1 and 2 of the exposure respectively. m 10 , m 20 , s Q i , where Q i ¼ ðQ i1 ; Q i2 Þ and Q ij ¼ Iði-th matched set is a discordant set and the case is exposed at the level jÞ, j ¼ 1; 2. For finite M, Y asymptotically follows a bivariate normal distribution and under H 0 it has mean ðm 10 ; m 20 Þ and variance covariance matrix D 0 . Hence, under the null hypothesis, S asymptotically follows a central Chi-square distribution with 2 degrees of freedom.
We propose the following test function for testing H 0 at level of significance a,
where c 2 2; a is the upper a percentile point of central chi-square distribution with 2 degrees of freedom. Remark 1 Note that for binary exposure variable the test statistic S reduces to
which is the same as Eq. (5.19) of Breslow and Day (1980) without continuity correction. As mentioned earlier, maximum likelihood estimators of the odds ratio parameters are obtained by solving a set of nonlinear equations in two variables and hence are not easy to obtain. Therefore, we provide a set of computationally simpler estimates following Mantel and Haenszel (1959) ,
The potential drawback of the Mantel-Haenszel estimator is that it does not use the information contained in the matched sets where the baseline category (level 0) does not appear, which may entail loss of efficiency.
Trend test for Ordinal Exposures
The proposed test statistic (8) is derived for categorical exposure variable with nominal levels. However, if there is some natural ordering in the exposure categories, specially for a quantitative variable, one may want to detect a linear trend in disease risk with increasing levels of the exposure variable, that means, we test H 0 : g ¼ 0 against H a : g 6 ¼ 0, where w l ¼ exp ðgx l Þ and x l is the value of the exposure variable at l-th level. Without loss of generality one may assume that x 0 ¼ 0 and x 1 < x 2 < . . . < x l . This is equivalent to assuming a prospective model for the disease probability logit PðD ¼ 1jx l Þ ¼ a i þ gx l , where a i defines the effect of i-th matched set on the disease probability. The above hypothesis can be restated in terms of the odds ratios of the exposure variable as
The trend test statistic first appear in the work of Armitage (1955) . The score test for detecting presence of a linear trend in (log) of odds ratios w l with increasing levels of the exposure variable is based on the statistic P 2 h¼0 x h N i 1h for every matched set, where N i 1h denotes the number of cases exposed at the level x h of the exposure variable in the i-th matched set. The score statistic for testing H 0 is
Note that e 0jT and v 0jT are the expectation and variance of
Þ. Under H 0 , the statistic asymptotically follows a central chi-squared distribution with 1 degrees of freedom and may be used to detect trend effects of the exposure on the disease risk.
Sample Size Determination

Categorical exposure variable: detecting association
To determine the power of the test as given in (8) Theorem Under the alternative hypothesis, S has approximate Chi square distribution with degrees freedom
and non-centrality parameter where c 2 n ðdÞ denotes chi-square distribution with n degrees of freedom and non-centrality parameter d.
Note that both the non-centrality parameter and degrees of freedom of the chi-squared distribution as specified above are functions of the number of matched sets N, the exposure prevalences in the control population, and the odds ratios. Therefore to determine the sample size for given values of exposure prevalences in the control population, the odds ratios, type-I error probability a, and type-II error probability b, we first calculate pr ðc 2 n ðdÞ ! c 2 a; 2 Þ for smallest possible value of N, and then we keep on increasing N by 1 until the above probability exceeds ð1 À bÞ. The value of N when we stop is reported as the required sample size.
Ordinal Categorical Exposure Variable: Detecting Trend
To determine required sample size to detect linear trend in disease risk with ordinal levels of exposure variable, we need to calculate the power function of the test defined in (16). Let, e 0 ¼ Eðe 0 j T Þ, v 0 ¼ Eðv 0 j T Þ, where these expectations are evaluated at w ¼ 1. Let the expectations evaluated at any value of w in the alternative space be denoted by,
. The exact expressions for e 1 and v 1 are collected in Appendix 5.
Then using standard asymptotics we write
where FðÁÞ stands for cumulative probability function for standard normal distribution. We use this power function to obtain the required sample size.
Remark 2 When the Type II error probability b is small, the last term on the right-hand side of (22) is negligible. In this case,
where, from the expressions of e i as collected in the appendix, we can write, e i ¼ Ne * i and v
, where e * i and v * i are free of N. It follows that,
6 Example and Simulation 6.1 Example 1: colorectal cancer in rats
The dataset we are considering is part of a large study conducted by a team of Texas A & M University researchers (Hong et al., 2001) to investigate the effect of dietary fat on the development of colon carcinogenesis in rats. In brief, colon cells replicate and spend their entire life cycle within crypts, finger like structures that grow into the wall of colon. The function of the normal crypts is to produce cells that line the colon. The entire study consists of 6 rats, and within each rat 20 crypts were considered, identified by the numbers 1 through 20. Here we focused on particular stem cells and noted if the cell has undergone apoptosis. Apoptosis is termed as programmed cell death or cell suicide in response to a variety of stimuli. This is a normal process in multicellular organisms. In our dataset a cell is considered as a case if it has undergone apoptosis and considered as a control cell otherwise. Cell proliferation is defined as growth in the number of cells due to reproduction and division of cells in a multicellular organism. For each stem cell in our dataset one has information on proliferation status which is categorized as no proliferation, medium proliferation, and high proliferation and would be considered as our exposure variable. There were a total of 214 stem cells which underwent apoptosis and we randomly selected three controls for each case using crypt as a matching variable. So, we formed a 1 : 3 matched case-control study with 214 total matched sets. In the following, we outline the computational steps for calculating the odds ratio and the proposed test statistic for this particular dataset. Note that here M ¼ 3. From Table 1 we get all the quantities needed to compute the estimates in (14) and (15), and we obtainŵ w 1MH ¼ 2:0975 andŵ w 1MH ¼ 11:20. In order to test the null hypothesis of no association between proliferation status and apoptosis, we calculate our test statistic in (8) using the following two steps.
Step 1. Using Table 1 we calculate Y 1 and Y 2 as described in (10) and (11) Step 2. Using formula (8), we obtain S ¼ 31:7608. So according to (12) we reject the null hypothesis of no association between proliferation and apoptosis at 5% level of significance.
Since there is a natural ordering among the proliferation status, we also perform a test of trend on the risk of apoptosis with increasing levels of proliferation as given in (16). For this dataset, we take x 1 ¼ 1 and x 2 ¼ 2, and e 0 j T ¼ 34:25; v 0 j T ¼ 30:9375. Hence by (16), the test statistics is c 2 ¼ 41:3111: Comparing with the chi-squared distribution (with df ¼ 1) cut-off value, we reject the null hypothesis of no trend effect at 5% level of significance. This finding, in fact conforms with the biological association expected between apoptosis and cell proliferation.
To do a realistic simulation we mimic the colon carcinogenesis dataset in hand. We note that among the controls, the prevalence of the different categories of the exposure variable are 0:9101, www.biometrical-journal.com 0:0799, and 0:01. With the above specifications of the exposure prevalence p 00 , p 01 , and p 02 respectively, we calculate the required sample sizes for different values of w 1 and w 2 . All the sample sizes are calculated after setting the Type I error probability a ¼ 0:05 and Type II error probability b ¼ 0:20. As expected one needs more sample for smaller values w 1 and w 2 compared to the higher values of the odds ratios as in the latter case, departures from the null hypothesis is more pronounced. The results are presented in Table 2 . In addition, we compute the required sample sizes for detecting trend with 3 ordered levels of the exposure variable using the power function (19) for different values of g. As expected, as g increases, the required number of matched sets decreases.
Example 2: association between disease and A genetic factor
In this example we first generate a prototype case-control dataset for exploring disease-gene association by mimicking a real data on allele frequencies of 12 marker loci in the Buenos Aires metropolitan population as described in Sala et al. (1999) , Table 3 . We chose the most frequent allele at marker locus F13A as the disease causing allele. This selection is arbitrary. Sala et al. (1999) reports the frequency of this allele in the population to be p ¼ 0:312. Assuming the population is in HardyWeinberg (HW) equilibrium we calculate the prevalence of three possible genotypes. If A denotes the disease causing allele, then PðAAÞ ¼ p 2 ¼ 0:0974, PðAaÞ ¼ 2pð1 À pÞ ¼ 0:4293, and PðaaÞ ¼ ð1 À pÞ 2 ¼ 0:473. Let g 0 , g 1 , and g 2 denote the genotypes aa, Aa, and AA. Note that though the bi-allelic gene is assumed to be in HW equilibrium in the general population, among the case and control population the genotype frequencies may not be in HW equilibrium. We assume that the logodds ratios of the disease among persons with no copy (aa), one copy (Aa), and two copies (AA) of the disease causing allele to be 0, 1, and 1, i.e., b 0 ¼ 0, b 1 ¼ 1 and b 2 ¼ 1. In other words, the disease risk is elevated if you have at least one copy of the disease causing allele. For generating the disease status data, we assume the prospective stratified logistic regression model for a matched case Table 2 Required sample size for detecting association in example 1, 1 : 3 matched study, where w 1 and w 2 are the two odds ratios. The type I error is set at 5% while the power is set at 80%. control study (Breslow et al. (1978) ),
where S i denotes the unmeasured or measured stratum specific covariates and a i is effect of the i-th matched set on the disease probability, i ¼ 1; . . . ; N (N is the number of matched sets).
To simulate a 1 : 2 matched case-control data with 100 matched sets, we first generate the genetic exposure variable G for each of the three subjects in every matched set according to the prevalence values mentioned before. Let G i1 , G i2 and G i3 denote the genetic exposure corresponding to the three subjects in the i-th matched set, i ¼ 1; . . . ; 100. Given these exposure values we determine the disease status D ij of the j-th subject in the i-th stratum following a conditional logistic regression model (Breslow et al. (1978) ), conditioning on the event that the number of cases in each matched set is pre-fixed by the study design to be 1. First, We generate a Bernoulli random variable D i1 with success probability
If D i1 equals 1, set D i2 and D i3 equal to zero. Otherwise, we generate D i2 from a Bernoulli distribution with success probability
Following the above scheme we generate N ¼ 100 matched sets with one case and three controls. Table 4 gives the summary of discordant matched sets in the simulated dataset. Note that here M ¼ 2. As in example 1, we first calculate the two odds ratio estimates given in (14) and (15), and they are,ŵ w 1MH ¼ 3:0 andŵ w 2MH ¼ 4:5. Next we calculate the test statistic to test the null hypothesis of no disease-exposure association by using the following two steps.
Step 1. Using Table 4 , Eqs. (10) and (11), and the formulas given in the Appendix we calculate Step 2. Plugging all the values in (8) we obtain the value of the test statistic S ¼ 18:19 with a P-value of 0:00014: So there is significant association between the disease and the candidate gene.
We also calculate the test statistic in (16) to see if there is any trend in the disease risk with increasing levels of the exposure variable (the three possible genotypes in this case with zero, one or two copies of the allele A respectively). The value of this test statistic turns out to be 15:434 which is statistically significant when compared with the chi-squared cut off value (with df ¼ 1) at 5% level of significance.
For the above scenario we calculate the required sample sizes to detect the departures from the null hypothesis of no association for given prevalence values and various choices of w 1 and w 2 . For the simulation, we assume that the exposure prevalence values in the control population are the same as in the overall population. This is equivalent to assuming the disease to be rare. Therefore we take p 01 ¼ 0:4293 and p 02 ¼ 0:0974. The results are presented in Table 5 .
We also calculate sample sizes for detecting trend with the ordered categorical exposure variable. The results are presented in Table 6 . All the sample sizes are calculated after setting a ¼ 0:05 and b ¼ 0:20. Figure 1 presents a plot of the power function against the required sample size when one wants to detect a given difference in w 1 and w 2 with a pre-specified probability (power) for a 1 : 2 matched study. The exposure prevalences are chosen as in the simulated dataset. With the same prevalence values of the exposure variable, we also calculate the power of the ordinal trend test for different sample sizes. Figure 2 presents two such power curves with g ¼ 0 and g ¼ 1 for a 1 : 2 matched casecontrol design.
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S. Sinha and B. Mukherjee: Score test for matched case-control studies Table 5 Required sample size for detecting association in example 2, 1 : 2 matched study, where w 1 and w 2 are the two odds ratios. The type I error is set at 5% while the power is set at 80%. Table 6 Required sample size for detecting trend in example 2, 1 : 2 matched study, where w 1 ¼ e g and w 2 ¼ e 2g are the two odds ratios, and N denotes the required number of matched sets. The type I error is set at 5% while the power is set at 80%. 
Binary exposure variable
In conjunction with our two examples, in this sub-section, we explore the performance of our method if the exposure levels are dichotomized. We compare our sample size recipe with the standard formula provided by Schlesselman (1982) . For 1 : 1 matched pair data with binary exposure, the required sample size (Schlesselman, 1982, Eqs. 6-20 and 6-23, Parker and Bregman, 1986, Eq. (3.1) , modified for a two-tailed test) is given as,
Where w is the odds ratio and p 01 is the exposure prevalence in the control population. This formula for sample size for pair-matched studies is based on the normal approximation to testing a single binomial proportion and a crude estimate of the probability of a discordant exposure pair. For 1 : M matched case-control study with binary exposure variable the number of matched sets required to attain a certain power of the test is the fraction ðM þ 1Þ=2M of the sample size required for 1:1 matched case-control design. According to Ury (1975) 1 : M matched design the needed sample size is N S ¼ ðM þ 1Þ N * S =2M. In contrast, according to our method the required sample size for binary exposure variable is derived based on the power function of the test statistic in (13). When the Type II error probability is small (set at 20% for our simulations), for binary exposure one could alternatively use (21) Here w ¼ p 11 p 00 =p 10 p 01 , where p 11 þ p 10 ¼ 1 and p 01 þ p 00 ¼ 1. Recall that for the binary exposure case our methods are essentially identical to that of Breslow and Day (1980, Chapter 5) . For the setting of the first example with 1 : 3 matching, in order to dichotomize the exposure, we collapse categories 1 and 2 of the exposure variable and call it category 1. Therefore the exposure prevalence among the control becomes p 01 ¼ 0:0799 þ 0:01 ¼ 0:0899. The sample size results are presented in Table 7 . Note that, the number of matched sets required by our method, is typically larger than those obtained by Schlesselman's formula. One of the reasons for Schlesselman's method to underestimate the sample size could be that obtaining the sample size formula for 1 : M studies by multiplying the sample size for 1 : 1 matched design with the factor of ðM þ 1Þ=2M may not always be optimal. The ad hoc estimate of probability of discordant exposure pairs used in Schlesselman's formula is often quite crude. Also note that the exposure prevalence is low in this setting as a result the required number of matched sets in both methods is relatively large. In the setting of the second example with 1 : 2 matched design for detecting disease-gene association, the prevalence of the genetic exposure after collapsing the categories G ¼ g 1 and G ¼ g 2 is given by p 01 ¼ 0:4293 þ 0:0974 ¼ 0:5267. The results comparing our method with those of Schlesselman are presented in Table 8 . In this case, our sample sizes are marginally larger than those of Schlesselman but both the methods furnish very similar sample sizes. Note that with larger prevalence of the genetic factor, the sample sizes for both the methods are smaller when compared with those obtained in Table 7 . Based on these simulation, the matching ratio, as well as the the exposure prevalence seems to play a role in determining the relative performances of these methods.
Parker and Bregman (1986) take Schlesselman's standard formula in (22) as a starting basis and incorporate the new dimension that the exposure prevalence p 01 could vary in each matched set. In presence of such heterogeneity, (22) normally underestimates the required sample size (Parker and Bregman, 1986) , thus the sample sizes obtained by Parker and Bregman will be typically larger than N S . Since the principal goal of this paper is to address exposure variables with multiple categories in a 1 : M matched study, for the binary exposure, we take Schlesselman's formula as a precursor for comparison purposes and refrain from specifically exploring the effect of stratum heterogeneity on sample size determination along the lines of Parker and Bregman (1986) .
Discussion and Final Comments
In this paper we furnish an easy to use recipe for determining the number of matched sets in a 1 : M matched case-control study with multiple levels of the exposure variable. In the process we derive a test statistic for the independence of the exposure and the disease variable when the categories are nominal and when they are ordinal. The advantage of this method is that it does not require computation of the MLE's of the parameters to perform the test, rather we can do the test by simply constructing tables of discordant matched sets. One may also derive a score test for testing homogeneity of the k odds ratios, i.e. H 0 : w 1 ¼ w 2 ¼ . . . ¼ w k , using the likelihood function we have used in this paper.
We briefly indicate that estimation of the common odds ratio following the classical ideas of Mantel and Haenszel (1959) but do not furnish standard error formulae. For interval estimation of the odds Table 7 Required sample sizes for 1:3 matched case-control study with binary exposure by Schlesselman's method and the method proposed in the current paper. Here w denotes the odds ratio. Exposure prevalence p 01 is set at 0.0899. The type I error is set at 5% while the power is set at 80%. ratio and derivation of the standard errors, one may resort to modern resampling techniques like the bootstrap as an alternative to establishing closed-form approximation formulae. However the goal of this paper is more modest. We focus on the designing issue when one wants to detect exposure-disease association in a matched case-control study with categorical exposure. Extension of the results to a set of multivariate categorical exposures which may be associated among themselves poses interesting technical challenges one might undertake. Admittedly, the approach presented in this paper is not the natural framework to deal with continuous exposure variables. In the most general setting, when one has a mixed set of continuous and discrete exposure variables, the problem needs to be recast in very different ways than proposed in this paper. A more general strategy to attack the design problem could be adopted by following simulation based design ideas as described in Mçller (1999) under a Bayesian paradigm. The R code for calculating the sample size and the datasets used in this paper are available on http://stat.tamu.edu/$sinha. be the number of matched sets where case is exposed at the level i and m r s subjects are exposed at the level r s , r s ¼ r 1 ; . . . ; r j and i 2 ðr 1 ; r 2 ; . . . ; r j Þ. Here m r 1 þ m r 2 þ . . . þ m r j ¼ M þ 1. Let S j be the set of all possible combinations of any j levels out of k þ 1 levels, j ¼ 2; . . . ; k þ 1.
S j is the collection of all possible combinations of at least two levels taken at a time from k þ 1 levels. Define ðA:9Þ
